Sitagliptin-Akrikhin
Sitagliptin-Akrikhin
On prescription
EDL in RU
Pharmacotherapeutic group:
agents for the treatment of diabetes mellitus; hypoglycemic agents other than insulin; dipeptidyl peptidase-4 (DPP-4) inhibitors
Active substance (INN):
Sitagliptin
Form of release:
film-coated tablets
Dosage:
100 mg
Dosages:
Pharmacovigilance & Drugs Safety
In accordance with the Russian laws, international standards, and corporate quality policy, Akrikhin performs safety and quality monitoring of the produced drug products throughout their life cycles. If an adverse drug reaction develops when using a drug product made by Akrikhin, please inform a pharmacovigilance specialist thereof
Contact us